Background Discrete choice experiments (DCEs) are widely used to quantify individuals' preferences for healthcare. Guidelines recommend the design of DCEs should be informed by qualitative research. However, only a few studies go beyond guidelines by fully presenting qualitative and quantitative research jointly together in a mixed methods approach (MMA). Objectives Using an example study about men's preferences for medical treatment of lower urinary tract symptoms (LUTS), we demonstrate how qualitative research can complement DCEs to gain a rich understanding of individuals' preferences. Methods We were the first to combine online discussion groups (ODGs) with an online DCE. A thematic analysis of the ODGs and a conceptual map provided insights into men's quality of life (QoL) with LUTS and relevant treatment attitudes. This was used to design the DCE. Men's willingness to pay (WTP) for these attributes was estimated. Findings from ODGs and DCE were compared to understand WTP and preference heterogeneity. Key findings Men mostly valued medicine that reduced urgency and night-time frequencies of urination but avoided sexual side effects. We find heterogeneity in the effect of sexual side effects on men's preferences. The ODGs suggest this is because several men may be sexually inactive due to their age, being widowed or having comorbidities. The ODGs also raised concern about men's awareness of LUTS. Conclusion We argue that the insights gained into men's preferences for treatment and how LUTS affects men's QoL could not have been obtained by either the qualitative research or the DCE alone.
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Key Points for Decision Makers
Guidelines recommend that discrete choice experiments (DCEs) should be informed by qualitative evidence. We go beyond these guidelines in a mixed methods approach (MMA) that treats qualitative findings and DCE results as being equally important.
In our study about men's treatment preferences for lower urinary tract symptoms (LUTS), we find treatment should relieve urgency and night-time symptoms while limiting sexual side effects.
The MMA has provided a richer understanding of treatment preferences than the DCE or qualitative research could have provided alone. Our qualitative data were collected in online discussion groups, which may offer a practical alternative to face-toface interviews, especially for target populations with limited mobility or sensitive research topics.
Introduction
Discrete choice experiments (DCEs) are widely used to elicit patient and population preferences for healthcare [1] . DCE surveys ask respondents to choose repeatedly between mutually exclusive hypothetical healthcare options characterised by a set of common attributes that take different levels [2] . Researchers select these attributes using literature reviews, pre-defined outcome measures, underlying behavioural hypotheses or qualitative research [3] . Attribute selection is fundamental to DCEs, and previous research has found that the number and type of attributes may affect the study outcome [4, 5] . While too many attributes may overburden respondents [6, 7] , too few attributes might induce omitted variable bias [8, 9] . Guidelines therefore recommend the use of qualitative research to identify and describe DCE attributes [3, 10] . This has improved the reporting of qualitative approaches in the DCE literature over the last couple of years, and is increasingly considered as an important quality aspect of DCE studies [11] . Systematic literature reviews of health DCEs find that qualitative research has informed attribute selection in 54% of studies and level selection in 35% of studies, and is used to test the quality of questionnaires [1, 12, 13] . However, few studies use qualitative research after the attribute selection and survey pre-testing phases of a DCE. For example, Vass et al. [11] found that only 4% of all health DCEs use qualitative research to collect additional evidence about individuals' preferences or attitudes. There are two potential explanations for this; first, journals have tight word limits, and second, guidelines only focus on the role of qualitative research for DCE design.
In this paper we argue that limiting the use of qualitative research to attribute selection does not uncover its full potential. Qualitative research is an established method in public health and other disciplines to gain insights into individuals' healthcare preferences, quality of life (QoL) and care context [14] [15] [16] [17] [18] . Qualitative research largely focuses on uncovering heterogeneity in views, contexts and opinions. Hence, qualitative research has a potential to provide detailed insights into causes and types of preference heterogeneity that is often only accounted for in DCE analysis by allowing preferences to be randomly distributed in the population [19] . We aim to demonstrate how qualitative and quantitative methods can be analysed and reported in parallel, using an example study about patients' preferences for medical treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Our mixed methods approach (MMA) recognises that qualitative and quantitative methods are complementary and together create a detailed understanding of individuals' preferences for healthcare. We are also the first to explore the use of online discussion groups (ODGs) as an alternative to traditional face-to-face focus groups to collect qualitative data alongside a DCE. ODGs can make qualitative research alongside a primarily quantitative study more practical than face-to-face alternatives. They may also be useful to collect data from a population with limited mobility. In the case of online DCEs, ODGs can also be used to ensure that all study participants are sampled from the same population.
Background of the Case Study
BPH is a chronic, progressive urological condition that affects aging men and is often associated with LUTS [20, 21] . LUTS comprise storage symptoms (daytime urinary frequency, night-time urinary frequency, urgency), voiding symptoms (e.g. slow stream, splitting or spraying, hesitancy, terminal dribble) or post-micturition symptoms (e.g. sensation of incomplete emptying). These symptoms reduce men's QoL and the health status of their partners [22] [23] [24] .
Several medical treatments are available for LUTS [21, 24] . These medicines have different profiles with regard to efficacy (e.g. reduced urge or frequency of voiding, or reduced prostate size) and side effects (e.g. reduced sexual functionality, and multiple non-sexual side effects). Previous studies have shown that men prefer medicine that maintains sexual activity in addition to relief of short-term and long-term symptoms [25, 26] . Preferences were also found to vary between men [26] . We suggest that qualitative research can help to better understand why men have different preferences for medical treatment of LUTS.
Mixed Methods

Study Overview
Our MMA was the first study that combined qualitative data from ODGs with quantitative online DCEs. The collected data was used in three ways (Fig. 1) . First, Fig. 1 Flow chart of the mixed method study. DCE discrete choice experiment qualitative analysis of the ODGs explored how LUTS affects men's life and men's attitudes towards medical treatment. Second, the ODGs were used to identify the DCE attributes, to frame the choice tasks and to define the 'no treatment' baseline. Third, the ODG results motivated the DCE analysis, informed the interpretation of the estimated trade-offs and provided insights into the overall validity of the quantitative findings.
While literature reviews, validated outcome measures, theoretical arguments and interviews have been used to inform the design of DCEs, face-to-face discussion groups have become increasingly popular for the identification of attributes and levels [1, 3, 11] . These discussion groups are usually recorded, transcribed verbatim and systematically analysed. In contrast, ODGs do not take place in real time; instead participants access a purpose-build website at any time during a pre-arranged period [27] . On this website, ODG participants can read comments of other participants or comment themselves.
ODGs are increasingly used in qualitative healthcare research [28] [29] [30] [31] . Data quality from ODGs is found to be comparable to face-to-face discussion groups, but researchers can reach a broader population with ODGs [32, 33] . The dedicated website is accessible from home at a time that is suitable for participants, which facilitates the inclusion of people who are housebound, have reduced mobility, or have busy schedules. ODGs can also be anonymous, which may facilitate the discussion of sensitive topics such as incontinence due to LUTS or sexual side effects of medicine [34, 35] .
Data Collection
Online Discussion Groups
Five moderated ODGs were conducted over 2 weeks to understand how LUTS affects men's QoL; to understand men's experience of, and attitudes towards, treatment of LUTS; to develop DCE attributes and levels; and to help inform subsequent DCE analysis.
Each ODG was 'live' for 1 week, started on Monday morning, and was moderated by three researchers (SH, DI, VW) identified by their names. At least one moderator was present daily between 8 am and 10 pm. A new question was posted every weekday (Table 1) . Participants could respond to these questions and other participants' comments. Moderators prompted for information and encouraged discussions. The final question was posted on Friday, and the website remained open until Monday morning.
All posted comments were downloaded and analysed independently by the moderators using an inductive thematic approach [36, 37] . Each researcher assigned codes that described topics, concerns or emotions in each post on the website. The codes were used to identify overarching themes. The three moderators discussed coding strategies and emerging themes in a 2-day workshop with the following objectives: (1) to gain insights into the effect of LUTS on men's QoL as well as attitudes towards medical treatment, and (2) to identify themes or sub-themes from the qualitative analysis that could be included as treatment attributes in the DCE. These themes or sub-themes had to be actionable, plausible in the context of treatment choice and tradeable [2] . This means that complex themes may need to be broken down into sub-themes (e.g. into different classes of side effects). Other themes may not be suitable at all for the inclusion as an attribute in the DCE (e.g. if it is unaffected by treatment choice). For the purpose of the workshop it was agreed in advance that disagreements were to be resolved through discussion and if this did not result in agreement, by majority vote. No voting was required in this study. As part of the workshop, a conceptual map was developed that linked themes and codes to explore interdependencies, by comparing which themes were discussed jointly in the ODGs. The purpose of the conceptual map was to graphically represent the wider context of the identified themes as well as how the different aspects that were raised in the ODGs relate to each other. The conceptual map therefore illustrates the complexity of the disease and treatment context, whereas the DCE reduces this complexity to the key attributes.
Discrete Choice Experiment
The DCE quantified the trade-offs that men make when choosing between LUTS treatments in terms of their willingness to pay (WTP) for each attribute and explored preference heterogeneity among men. Seven attributes were used to describe medical treatments of LUTS (Table 2) . Three attributes (daytime and night-time frequency of urination and daytime urgency) represented symptoms that men experience and that medication can potentially improve. Two attributes describe the side effects of medications. A cost attribute allowed the estimation of WTP for changes in each attribute and was described as ''all the costs involved in obtaining a prescription and having it dispensed including the travel costs such as bus fares, petrol costs, car parking charges, time off work, and any prescription fee''. The cost attribute levels were based on previous studies [25, 26] .
A D-efficient design with flat priors combined the attributes and levels into 30 choice sets, which were split into three blocks of equal size [38] . Each choice set included two hypothetical LUTS treatments and an opt-out option. The opt-out was described as a no-treatment option Table 1 Online discussion groups: questions posed by moderators Welcome (day 1) Welcome to this online bulletin board about the treatment of urinary symptoms. Your answers to the short questionnaire last week indicate that you experience symptoms such as: • A frequent need to go to the toilet, day or night
• The feeling of delay or hesitation when you start to urinate
• The feeling that you cannot empty your bladder completely
• The feeling that you must urinate right away
We would like to understand:
• How these symptoms affect your day-to-day life
• If you receive treatment
• What men like you think about different aspects of the available treatments for these symptoms To help us understand, each day we will ask you a question. We are interested in your answers to these questions and the answers of the group. You might find other people's answers interesting and/or different from your own. Throughout there are no right or wrong answers, we are interested in your opinion. Thank you very much for agreeing to take part and sharing your opinion with us
Urinary symptoms and your day-to-day life (day 1)
In the short questionnaire last week, you indicated that you experience symptoms such as:
• A frequent need to go to the toilet, day or night
Can you tell us how these symptoms affect your day-to-day life?
Managing your symptoms (day 2)
Thank you for all your comments on Monday. They were really useful to help us understand how your symptoms affect your life. Today, we would like to understand how you manage your symptoms. Do you take any medicine to help manage your symptoms? If you take medicine, are you satisfied with the effect this has on your symptoms? If you don't take medicine, could you tell us why? (There are no right or wrong answers; we are interested in your opinion). Thanks again for all your help
Medicine side effects (day 3)
Yesterday we were discussing medicines. Some people take medication and they said it can help with their symptoms. Other people don't take medication for several reasons. Today we would like to discuss the different side effects that medicines might have. Different medicines have different side effects. But the most frequently reported side effects of medicine to treat urinary symptoms are: • Headaches 
Final comments (day 5)
Today is the last day on which we will post a new topic to the bulletin board. The bulletin board will close on Monday morning. We have found all of your thoughtful responses and comments very helpful, and we would like to thank you very much for taking the time to contribute. Today we would like to ask you questions about the bulletin boards this week: Have you been surprised by the topics that we have discussed? Did we miss something that you expected to come up? Overall, how have you found the experience of taking part in the bulletin board this week? Many thanks and best wishes with a daytime frequency of 14 times, a night-time frequency of four times, urge incontinence and no side effects. These relatively severe levels were chosen to allow for sufficient variation in symptom improvement by medicine [39] . Figure 2 presents an example choice set. Attribute levels of the treatment alternatives and the opt-out were chosen such that treatment could not worsen LUTS. The opt-out levels were introduced by asking men to imagine that they urinated 14 times during the day, woke up four times to urinate during the night and experienced urge incontinence (Fig. 2) . A link to a description of this baseline scenario was placed above each choice set.
The data analysis was based on random utility theory [40] and assumed that utility u jnt for respondent n, derived from alternative j in choice t, can be split into a deterministic part v jnt and a random part e jnt , such that:
The deterministic part of Eq. (1) was specified as a linear function of the attributes: with b n being an individual specific vector of marginal utilities and x jnt denoting the vector of attributes. The ODGs suggested that preferences varied between men, and marginal utilities were therefore assumed to be distributed with a probability distribution f ðb kn j b k ; r k Þ, where b k denotes the mean and r k the standard deviation (SD). The resulting mixed logit was estimated with 3000 Halton draws from f ðb kn j b k ; r k Þ [41] . Daytime and night-time frequencies were assumed to be log-normal distributed to avoid an implausibly large share of respondents preferring a higher frequency of urination. The cost attribute was fixed to ensure that probability distributions of parameter ratios had existing moments, and the number of tablets was fixed, because no specification resulted in either a significant mean or a significant SD. The remaining attributes were normal distributed. Mean WTP estimates were obtained as the ratio between the estimated coefficient for an attribute and the negative cost coefficient; 95% confidence intervals for WTP estimates were calculated using the delta method [42] . All categorical attributes were dummy coded. More details about the model are provided in a separate publication [39] .
Recruitment
Men residing in the UK who were registered with a commercially managed online access panel were invited to participate in the study if they were of C45 years of age and had a self-reported International Prostate Symptom Score (IPSS) of C8. These criteria are associated with increased prevalence of storage symptoms [21] .
Forty-eight eligible men were invited to participate in an ODG and received detailed information. Informed consent was obtained, and men were asked to provide dates on which they would be available. Men registered with a username and password to the website and were identified in the ODG only by their username. Users registered to the website were split into groups of seven to ten men with similar distributions of age and IPSS. Participants received £30 for contributing at least three comments.
Five thousand two hundred and twelve men who did not participate in the ODGs were invited to the DCE. Men received information about the medical background, the survey structure and completion time. Respondents received £1.50 for a completed questionnaire. The sampling was paused for 1 week after 63 respondents had completed the questionnaire, and this data were used as the pilot and resulted in a minor adjustment of the cost attribute based on an unexpected opt-out rate of 33%. Further details on the pilot are presented in a separate publication [39] .
Results
Online Discussion Groups
Twenty-two men actively participated in the ODGs. Men had a mean age of 59.82 years and a mean IPSS of 16.41. A total of 223 comments were made across all ODGs (3-22 posts per active participant).
Seven themes were identified: (1) men's symptom awareness; (2) experience of daytime frequency and urgency; (3) experience of night-time frequency and urgency; (4) determinants and experiences of consulting a doctor; (5) attitudes to side effects; (6) psychological wellbeing; and (7) determinants of self-care. Figure 3 presents the conceptual map of these themes.
Awareness
All men found their LUTS bothersome, but not all men associated their symptoms with a medical condition, and some men were unaware that their symptoms were more severe than what is 'normal' for men their age. For example, participant 1 in group 5 wrote: ''It is […] accepted that as a man when you grow older you are likely to want to use the toilet a lot more and is sometimes treated as a bit of a joke, which probably contributes to men not paying too much attention to it.'' Some men had spoken with their general practitioner (GP) and were told that their symptoms were age related. Participant 3 in group 4 wrote: ''I have been to see a doctor […] when I was having to go to the toilet 2 or 3 times [at night]. She said it was of no concern and that it is normal for a man my age.''
Daytime Symptoms
Men often discussed the impact of daytime frequency and urgency on their life. Frequently needing to urinate was annoying, disruptive, embarrassing and confining to men. For example, participant 10 in group 1 wrote: ''I would normally only go to places where I know where the toilet is. If it's a new place I have to make sure I go before leaving the house. This can take a while so going anywhere always takes longer than it would for others.'' If men's careful plans were disrupted, by delays or traffic congestion, this was stressful. Participant 9 from group 2 wrote: ''Until recently, I had a 3.5 hour drive most Monday mornings and the same on Thursday nights. I would anticipate wanting to stop around 1.5 to 2 hours out and judge which service station to stop at. Occasionally I misjudge it, or get stuck in traffic, and then it becomes uncomfortable. This tends to results in a lot of swearing at other road users or traffic lights, if I'm […] getting near my limit.'' Working men were concerned about how urination frequency affected their work. For example, participant 3 in group 4 wrote: ''Recently, it has started to affect my work and I have to go at least four times during the shift.'' Urinary urgency restricts men's lives and decreases their self-confidence. Several of the participating men seldom leave home and restrict their social life, because they are afraid of not reaching the toilet on time. For example, participant 8 in group 3 wrote: ''To minimize accidents I use incontinence pads, which although are a nuisance they help me feel more confident if I am going out. This condition wears me down and makes me feel like a lesser man.''
Night-Time Symptoms
The most frequent response to how LUTS affected men's life was related to night-time urination frequency. Nighttime urgency was also mentioned and linked to wetting the bed. For example, participant 6 in group 5 wrote: ''I am still getting up during the night, it is such a horrible thing. You are fast sleep one moment and the next you are awake and trying to get to the toilet as quick as possible.'' Some men reported that their disturbed sleep meant that they were tired during the day. Participant 2 in group 2 wrote: ''I often feel tired and sleepy in the afternoons and frequently fall asleep on the sofa in the evenings. This means I get very little leisure time as when I finally sit down and read a book or watch TV I am too tired and will fall asleep.'' Men who experienced urgency symptoms at night had experienced incontinence or were worried about it. This reduced their confidence, enjoyment of trips away from home and caused worry about the effect on their partner whose sleep was disturbed, too. We now have separate beds, and also sometimes I have been in such a deep sleep that I have accidents during the night, and then my wife has to change the bed in the middle of the night.
[…] My wife never says anything she just does it as if it is a part of normal life, but I can tell after 40 years of being together she does find it all stressful.'' 
Doctor
Not all men had consulted their GP. Men gave three main reasons for not consulting a GP. First, their symptoms were perceived as not ''too bad''. Second, they believed doctors could not do anything. Third, they did not want to take medication. A minority of men were also scared of their symptoms being associated with prostate cancer. In general, LUTS getting ''too bad'' was not an absolute concept, but related to a deterioration in symptoms that substantially decreased QoL. For example, participant 9 in group 2 wrote:
''I put up with the situation for quite a while and just thought 'well that's just the way I am'. Also inherited a fear of doctors (they find nasty stuff and maybe I'd rather not know). What finally forced the issue was when I started getting urine infections and the pain and frequency of needing to go to the toilet and loss of control…''
Side Effects
Sexual side effects were perceived as more important than non-sexual side effects for most men. For example, participant 16 in group 2 wrote: ''Headaches, dizziness, a dry mouth are not too bad, but I am having enough issues with no fluid during ejaculation, inability to get or maintain an erection, decreased sexual desire as it is …''
The importance of sexual side effects to a man depended on his circumstances. Some men were already experiencing sexual symptoms. Men who were living alone and were no longer sexually active stated that the sexual side effects were irrelevant to them. For example, participant 5 in group 3 wrote: ''I am totally impotent, prior to this my GP wanted to prescribe Viagra. As a widower of advanced years (72) the impotence does not bother me, so the sexual side of my life is one less problem to worry about […] .''
Psychological Well-Being
LUTS affects men's psychological well-being. Many worried about going to the toilet when being out, about having an accident and about staying overnight away from home. Men felt guilty about how their symptoms affected their family or felt trapped at home, because they were afraid of not finding a toilet. For example, participant 6 in group 5, who experienced severe storage symptoms, wrote:
''I am unable to just nip into town as the only public toilet that was there has been closed. […] This is a terrible strain on my relationship with my wife, although she fully understands and is very comforting to me when I get upset, because I feel like a prisoner in my own home at times, because of this problem.''
Self-Care
Men had different strategies for self-care or to manage their LUTS. They were conscious of, and sometimes limited, their fluid intake. Not all men believed that this worked.
Other men wrote about trying to hold on and not to ''give in'' to the urge to urinate. For example, participant 1 in group 5 wrote:
enerally more conscious about how much I drink during the day, mainly tea, especially with regard to what I will do in the following hours, e.g., long drive. Usually do not drink anything after about 6pm or I will almost certainly have to get up in the night.''
The ODGs showed that LUTS reduce men's QoL and that men organise their day to manage the symptoms. Many men were not aware that LUTS is treatable by medicine, and many had not contacted their GP. This supports our use of online recruitment from the general population using symptom score as an inclusion criterion. In doing so, we have included a wider group of men than would have been reached by patient groups.
The ODG informed our attributes. We include daytime and night-time frequency of urination and urgency as attributes because these were symptoms most frequently discussed and those that potentially can be improved with treatment. The attribute and levels echo the ways in which men discussed frequency and urgency in the ODGs. We expected men to value reduced daytime urination frequency, because they can take part in more daily activities, and to value reduced nighttime frequency, because they would have better sleep quality. We included a broad range of side effects. In the ODGs, men's circumstances affected their willingness to take medication with side effects. Men who were sexually inactive were less concerned about sexual side effects of treatment; therefore we expected to find significant preference heterogeneity for side effects in the DCE results. The range of experiences and symptoms reported in the ODGs meant that we chose to define a baseline situation in the DCE to ensure that the DCE made sense to all respondents.
Discrete Choice Experiment
One thousand and ninety-seven men opened the online survey, of which 450 were screened out. A total of 136 men met the eligibility criteria, but were over the sampling quota of 310 respondents. A total of 201 men dropped out before completing all the questions, and 63 were used for the pilot study. The final survey was completed by 247 men, resulting in 7410 observations for the DCE analysis. Men had a mean age of 62.32 years and a mean IPSS of 15.69. In the sample, 112 men had discussed LUTS with their GP, and 65 (58.04%) of these men had received medical treatment. Figure 4 presents the mean WTP estimates based on the mixed logit model results. A full set of estimates is reported by Mankowski et al. [39] . WTP estimates show how much men are willing to pay per month for a marginal change in each of the significant attributes (p \ 0.05). The DCE showed that men value medicine, especially if it reduces urinary urgency. However, men's valuation is reduced by side effects, especially sexual side effects. Three coefficients were insignificant (estimate, p value): the reduction in urgency from incontinence to severe urgency, the side effect of dry mouth, and number of tablets per day. While it is surprising that a change from urge incontinence to severe urgency is not significantly valued by men, one explanation may be that even under severe urgency, men are still afraid of wetting themselves while rushing to the toilet. It may be this fear together with the requirement of rushing to toilets that prevents the change in urgency to be valued by men. Men may also be affected by past experience of incontinence. For example, participant 231 in group 1 stated: ''Several years ago I did wet the bed and this sometimes makes me a little apprehensive when we are away.'' Men were willing to pay more to improve urination urgency than to reduce urination frequency. Reducing urgency from incontinence to mild urgency was valued at £25.33 per month, and reducing urgency from incontinence to moderate urgency was valued at £23.93 per month. Men were willing to pay more for a one-time reduction in nighttime frequency than daytime frequency of urination (£6.65 per month and £1.39 per month, respectively).
Erectile dysfunction was the worst side effect, and reduced the value of medication by £30.07 per month. The remaining sexual side effects (no fluid during ejaculation and decreased sexual desire) and non-sexual side effects (headache and dizziness) reduced the value of medication by similar values (between £16.26 and £19.66 per month).
Preferences were found to be heterogeneously distributed in the population for both frequency attributes, all levels of the urgency attribute except for an improvement to mild urgency, all levels of the sexual side effects attribute except no fluid during ejaculation, and all levels of the non-sexual side effect attribute except dry mouth. In line with our expectations, we find significant preference Fig. 4 Men's mean willingness to pay (WTP) for each attribute: *p\ 0.005; **p \ 0.001. WTP estimates show the value that men put on each attribute (and level) of medication. For urinary frequency, the estimates are for a reduction in frequency of 1 time. For urinary urgency, the estimates are for a change from urge incontinence to the specified level of urgency. For side effects, the estimates are for the occurrence of the stated side effect vs. no side effect. Bars above the horizontal axis denote attributes that have a positive effect on utility and men are willing to pay for that attribute. Bars below the horizontal axis denote attributes that have a negative effect on utility and men are willing to pay to avoid that attribute. Error bars denote 95% confidence intervals (CIs). Insignificant WTP estimates are excluded from the graph: constant = -£6.53 (95% CI -16.73 to 3.68), severe urgency = -£1.93, dry mouth = -£2.85 (-9.14 to 3.44), number of tablets = £1.43 (-2.10 to 4.96) heterogeneity for the 'decreased sexual desire' and 'impotence levels' of the sexual side effects attribute (Fig. 5) . More details on estimated SDs are provided in [39] .
Discussion
This paper presents one of the first MMAs in the health literature that combines a DCE with qualitative research [11] . Previous studies have mostly published qualitative findings and DCE results separately [43] [44] [45] [46] or conducted an MMA using non-economic quantitative techniques, such as rating or ranking [47] . Current DCE guidelines recommend the use of qualitative research at the study design stage. Our findings suggest that qualitative research can complement DCEs at the analysis and interpretation stage as well. Qualitative research can provide insights into patients' preferences and attitudes that cannot be obtained by a DCE. For example, the inclusion of random parameters in our statistical analysis of the DCE data allowed us to control for preference uncertainty [19] , but it did not explain these idiosyncratic differences between respondents in terms of differences in personal circumstances, tastes and expectations. Qualitative research can also provide insights into causes of relative attribute importance. In our DCE, we found that reducing night-time frequency was more important than daytime frequency. The ODGs suggested that this is because night-time frequency disturbs patients' sleep as well as the sleep of their partners. Therefore, WTP for improving night-time frequency in the DCE includes the value of improved sleep for men and their family. Other aspects of patients' treatment choice may simply not be picked up by a DCE. For example, a key finding of our qualitative analysis was that men were often unaware of LUTS being treatable and therefore had not talked about their symptoms with their doctor or family.
While our findings suggest that an MMA would enhance most, if not all, DCEs, some issues remain to be resolved. Reporting guidelines for DCEs and qualitative research have become complex and require the provision of several method-specific study details [48] [49] [50] . Fulfilling all of these recommendations may not be possible in one journal publication. The high interdependency between qualitative research and DCEs also results in an unclear and potentially unnatural presentation ordering. While the DCE attributes are results of the qualitative research, they are not the only qualitative research output. This may suggest that all qualitative research should be presented before the DCE is discussed. However, such a reporting structure would reduce researchers' ability to discuss and compare qualitative evidence together as a common picture that emerges from studying treatment preferences in an MMA. We therefore advocate a more interwoven reporting approach. To make such an approach more practical and transparent, future discussions about reporting standards of MMAs are needed.
Our study was also the first to combine an online DCE with ODGs. ODGs may offer a practical and less costly alternative to face-to-face interviews or focus groups. When ODG are undertaken alongside online quantitative surveys, the ODGs allow researchers to sample all study participants from the same population. ODGs also enable people with limited mobility to participate in the study. Furthermore, we found that using an anonymous username as an identifier helped in the discussion of sensitive topics. One participant in discussion group 3, for example, stated:
''As you are only a username and not a physical being it is easier to express your feelings as you are not watched and are unaccountable. It gives you more freedom and lifts the 'taboo' barrier.'' There are some disadvantages of ODGs over face-toface discussion groups. The asynchronous nature of ODGs reduces the amount of interaction between participants, and Fig. 5 The distribution of willingness to pay (WTP) for sexual side effects in the discrete choice experiment sample. Distributions are based on the conditional parameter distribution of the sample [5, 19] . The negative WTP means that men's valuation decreases if a medicine has side effects. a Reduced sexual desire and b importance moderators are less likely to be able to engage all participants in discussions. However, these issues may be reduced by providing a participation-based incentive (e.g. a minimum number of postings). Furthermore, little is known about how the anonymity affects the validity of participants' responses. Future studies should therefore build on this study by exploring ODGs in a different health context or by comparing ODGs with face-to-face qualitative methods.
Our study contributes to a broad range of different literatures. First, the DCE adds to the limited evidence of patients' preferences for medical treatment of LUTS associated with BPH. Previous studies have mainly focussed on men's preferences for treating BPH (e.g. by decreasing the size of the prostate) [25, 26] . In contrast, our study focuses on how men experience LUTS and how this experience changes due to medical treatment. Second, our qualitative research extends the findings from other studies that show LUTS can have a severe effect on the QoL of men and their partners [22, 23, 51] . Third, our discussion of combining and reporting DCEs together with qualitative research in an MMA builds on and extends previous work that explores how qualitative research can inform the design of DCEs [3, 10, 11, [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] .
Our analysis is subject to some limitations. (1) The ODGs suggested that some of the preference heterogeneity around the sexual side effects attribute is caused by the degree to which men are sexually active. We did not collect such data in the DCE questionnaire and could therefore not account for sexual activity in our analysis. However, sexual activity is only one of several reasons for preference heterogeneity in the valuation of the sexual side effects attribute. This is why we assumed parameters to be randomly distributed in the population. (2) As noted by Mankowski et al. [39] , our results may not be representative for all patients suffering from LUTS due to BPH. Using the online access panel, we achieved an estimated recruitment rate of 14.58%, but have no information about how responders differed from non-responders or the UK population that is not signed up to the panel. (3) Our DCE assumes that taking no medicine results in a fixed set of symptoms and does not allow for any changes in LUTS due to progression of BPH. We have chosen to fix the opt-out alternative to a defined scenario to make choices comparable and to avoid instances in which taking medicine resulted in worse scenarios than taking no medicine. (4) Our sampling criteria rely on self-reported IPSS, which is not equivalent to a clear medical diagnosis, and as a result, men may be suffering from other diseases, such as urinary tract infections or prostatic cancer. Using self-reports also allowed us to explore men's disease awareness in the ODGs, which is in line with studies that find low consultation rates for men suffering from LUTS [64] . (5) The DCE only considered storage symptoms of LUTS, because these symptoms were found to be the most bothersome to men in the ODGs. However, this is in line with findings from other studies in the literature [65, 66] .
Conclusion
This paper went beyond the recommendations of DCE guidelines by showing how qualitative methods can complement a DCE. Our MMA informed the DCE attributes and levels, provided behavioural insights on its own and informed the interpretation of DCE parameter estimates. As a result, the MMA provided more detailed insights into patients' preferences than qualitative or quantitative research could have provided alone.
